Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation
Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation
Recruiting · NCT06339775 · Registry updated 2024-04-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Recruiting | Phase 4 | 2024-04-01 | NCT06339775 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Suping ZHANG | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Zhengzhou University | Zhenzhou | China | 3 |